Brief: Spyre Therapeutics Announces Proposed Public Offering Of Its Common Stock
05/10/2026 21:03
BRIEF-Spyre Therapeutics Announces Proposed Public Offering Of Its Common Stock Oct 5 (Reuters) - Spyre Therapeutics Inc SYRE.O:
SPYRE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF ITS COMMON STOCK
SPYRE THERAPEUTICS - NET PROCEEDS INTENDED FOR ADVANCING PROGRAMS AND SPY072 LATE-STAGE DEVELOPMENT
Source text: ID:nGNX5lq6TL
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock